A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children
American Journal of Epidemiology · 02.06.2023 · 192 (6) · 916-928
DOI: 10.1093/aje/kwad054 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Epidemiology, online erschienen am 09.03.2023. Verfasst von Dwight E Yin und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: HIV Protease Inhibitors, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, NIDDK NIH HHS, NIAID NIH HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Protocol adherence may influence measured treatment effectiveness in randomized controlled trials. Using data from a multicenter trial (Europe and the Americas, 2002–2009) of children with human immunodeficiency virus type 1 who had been randomized to receive initial protease inhibitor (PI) versus nonnucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral therapy regimens, we generated time-to-event intention-to-treat (ITT) estimates of treatment effectiveness, applied inverse-probability-of-censoring weights to generate per-protocol efficacy estimates, and compared shifts from ITT to per-protocol estimates across and within treatment arms. In ITT analyses, 263 participants experienced 4-year treatment failure probabilities of 41.3% for PIs and 39.5% for NNRTIs (risk difference = 1.8% (95% confidence interval (CI): −10.1, 13.7); hazard ratio = 1.09 (95% CI: 0.74, 1.60)). In per-protocol analyses, failure probabilities were 35.6% for PIs and 29.2% for NNRTIs (risk difference = 6.4% (95% CI: −6.7, 19.4); hazard ratio = 1.30 (95% CI: 0.80, 2.12)). Within-arm shifts in failure probabilities from ITT to per-protocol analyses were 5.7% for PIs and 10.3% for NNRTIs. Protocol nonadherence was nondifferential across arms, suggesting that possibly better NNRTI efficacy may have been masked by differences in within-arm shifts deriving from differential regimen forgiveness, residual confounding, or chance. A per-protocol approach using inverse-probability-of-censoring weights facilitated evaluation of relationships among adherence, efficacy, and forgiveness applicable to pediatric oral antiretroviral regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NICHD NIH HHS
- NIDDK NIH HHS
- NIAID NIH HHS
- Medical Research Council
- National Institutes of Health
- National Institute of Mental Health
Zitieren
APA
Yin, D. E., Cole, S. R., Ludema, C., Brookhart, M. A., Golin, C. E., Miller, W. C., & McKinney, R. E. (2023). A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children. American Journal of Epidemiology, 192(6), 916-928. https://doi.org/10.1093/aje/kwad054
Vancouver
Yin DE, Cole SR, Ludema C, Brookhart MA, Golin CE, Miller WC, et al. A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children. American Journal of Epidemiology. 2023;192(6):916-928. doi:10.1093/aje/kwad054
BibTeX
@article{Yin2023,
author = {Yin, Dwight E and Cole, Stephen R and Ludema, Christina and Brookhart, M Alan and Golin, Carol E and Miller, William C and McKinney, Ross E},
title = {A Per-Protocol Analysis Using Inverse-Probability-of-Censoring Weights in a Randomized Trial of Initial Protease Inhibitor Versus Nonnucleoside Reverse Transcriptase Inhibitor Regimens in Children},
journal = {American Journal of Epidemiology},
year = {2023},
volume = {192},
number = {6},
pages = {916--928},
doi = {10.1093/aje/kwad054}
}
EUVIMED